Prospective evaluation of Peginterferon alfa-2A (40KD)-Ribavirin in CHC, IFN/Ribavirin nonresponders/relapsers (2003)
- Authors:
- Autor USP: MARTINELLI, ANA DE LOURDES CANDOLO - FMRP
- Unidade: FMRP
- Assunto: HEPATOPATIAS (TRATAMENTO)
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of Hepatology
- ISSN: 0168-8278
- Volume/Número/Paginação/Ano: v. 38, supl.2, p. 161, res. 555, 2003
- Conference titles: Annual Meeting of the European Association for Study of the liver (EASL2003
-
ABNT
PARISE, E. et al. Prospective evaluation of Peginterferon alfa-2A (40KD)-Ribavirin in CHC, IFN/Ribavirin nonresponders/relapsers. Journal of Hepatology. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 24 abr. 2024. , 2003 -
APA
Parise, E., Meirelles, A., Martinelli, A. de L. C., Lacet, C., Corrêa, E., Cotrim, H., et al. (2003). Prospective evaluation of Peginterferon alfa-2A (40KD)-Ribavirin in CHC, IFN/Ribavirin nonresponders/relapsers. Journal of Hepatology. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Parise E, Meirelles A, Martinelli A de LC, Lacet C, Corrêa E, Cotrim H, Sette H, Cheinquer H, Gallizi J, Fonseca J, Paraná R, Silva R, Spinelli V, Gomes A, Crespo D, Lima L, Pereira L, Teixeira R, Amorim W, Tatsch F. Prospective evaluation of Peginterferon alfa-2A (40KD)-Ribavirin in CHC, IFN/Ribavirin nonresponders/relapsers. Journal of Hepatology. 2003 ; 38 161.[citado 2024 abr. 24 ] -
Vancouver
Parise E, Meirelles A, Martinelli A de LC, Lacet C, Corrêa E, Cotrim H, Sette H, Cheinquer H, Gallizi J, Fonseca J, Paraná R, Silva R, Spinelli V, Gomes A, Crespo D, Lima L, Pereira L, Teixeira R, Amorim W, Tatsch F. Prospective evaluation of Peginterferon alfa-2A (40KD)-Ribavirin in CHC, IFN/Ribavirin nonresponders/relapsers. Journal of Hepatology. 2003 ; 38 161.[citado 2024 abr. 24 ] - Alterações no sistema hepático de biotransformação do acetaminofen em ratos submetidos a modelo experimental (ingestão exclusiva de sacaroses) que previne efeitos hepatotóxicos da droga
- Relationship between concentration of hcv rna in the serum and its presence in saliva in patients with chronic hepatitis c
- Relationship between concentration of hcv rna in the serum and its presence in saliva in patients with chronic hepatitis c
- Hemorragia digestiva alta (HDA) em cirróticos: ocorrência e fatores relacionados. Experiência do HC-FMRP-USP
- Anticoagulation for liver fibrosis: a pilot study in hepatitis C infected patients
- HCV RNA <15 IU/mL at week 4 is highly predictive of SVR among HCV G2/3 patients receiving peginterferon alfa-2A/RBV: final results from potente study
- Peginterferon Alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels
- Effect of a thrombin receptor(protease-activated receptor 1-PAR-1)gene polymorphism in chronic hepatitis C liver fibrosis
- Ictericia
- Correlation between the levels of hcv in serem and liver of patientes with chronic hepatites
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas